Kim Kardashian West’s Instagram account is drawing attention, although not the kind she likes.
The Food and Drug Administration sent her a warning letter for a picture she posted in which she’s posing with a morning sickness drug. Not only ddi she fail to disclose the drug’s side effects to her 42.4 million followers, she also broke her own vow to keep her account off-limits to brands.
Kardashian tweeted and posted to Instagram a picture on July 19 of a medication called Diclegis, which boasts it’s the only “FDA approved medicine for treatment of morning sickness.” Since she was so “excited and happy” with it, she wrote on Instagram that she’s “partnering” with them to promote it.
Well, the endorsement didn’t sit well with the FDA proving that even the governmental agency keeps up with the Kardashians, albeit slowly. The agency slammed her for not including risk and side effects information on her Instagram caption in a five-page letter dated Aug. 7.
Kardashian included a (non-clickable) link to a safety webpage, but that wasn’t enough.
“By omitting the risks associated with Diclegis, the social media post misleadingly fails to provide material information about the consequences that may result from the use of the drug and suggests that it is safer than demonstrated,” the FDA said.
The Instagram post has been deleted as of Tuesday afternoon, but the tweet has not.
Diclegis’ maker, Duchesnay, told CNBC that it takes government warnings “very seriously” and admitted that Kardashian’s Instagram post needs to be “in accordance with applicable rules and regulations.” That explains why the Instagram post was deleted.
Now that she has complied with the FDA’s request, her Instagram account is back to favoring selfies over sponsors — for now.
More in Marketing
At the Las Vegas Grand Prix, Mastercard joins a pack of consumer brands flocking to Formula One
For marketers looking to align their brands with F1’s expanded appeal to audiences, the Las Vegas Grand Prix is providing a slip road into the sport.
Why PepsiCo and EA are expanding their partnership into mobile: A Q&A with PepsiCo vp of global sports and entertainment partnerships Adam Warner
The planned, multi-year nature of PepsiCo’s integration into “EA Sports FC” reflects that both PepsiCo and Electronic Arts are playing the long game as they look to step up the presence of ads inside and beyond EA’s portfolio of sports titles.
Key takeaways from Digiday’s 2024 Gaming Advertising Forum
Now that gaming has gone from a buzzword to a regular presence in brands’ media mix, marketers are more closely scrutinizing the value and ROI of their investments in this channel — and the platforms are rising to the challenge. Here are some of the biggest takeaways from this week’s Gaming Advertising Forum.